Arrowstreet Capital, Limited Partnership Lantheus Holdings, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$114 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $296,716 - $396,590	5,810 New	5,810 $362,000
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $18.2 Million - $22 Million	220,863 Added 78.89%	500,835 $42 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $1.94 Million - $3.36 Million	40,565 Added 16.94%	279,972 $23.1 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $3.24 Million - $5.16 Million	-66,490 Reduced 21.74%	239,407 $12.2 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $9.23 Million - $13 Million	150,272 Added 96.56%	305,897 $21.5 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $754,344 - $986,732	13,582 Added 9.56%	155,625 $10.3 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $3.45 Million - $8.05 Million	142,043 New	142,043 $7.86 Million
Q4 2021 Feb 14, 2022	SELL	$22.54 - $30.44 $7.66 Million - $10.3 Million	-339,967 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$24.23 - $28.59 $6.75 Million - $7.97 Million	278,647 Added 454.41%	339,967 $8.73 Million
Q2 2021 Aug 13, 2021	BUY	$19.51 - $27.64 $1.2 Million - $1.69 Million	61,320 New	61,320 $1.7 Million
Q1 2021 May 14, 2021	SELL	$13.77 - $21.66 $3.4 Million - $5.34 Million	-246,756 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$10.75 - $14.91 $2.82 Million - $3.91 Million	-262,429 Reduced 51.54%	246,756 $3.33 Million
Q3 2020 Nov 12, 2020	SELL	$11.98 - $16.34 $1.82 Million - $2.49 Million	-152,258 Reduced 23.02%	509,185 $6.45 Million
Q2 2020 Aug 12, 2020	BUY	$10.34 - $15.51 $1 Million - $1.51 Million	97,049 Added 17.2%	661,443 $9.46 Million
Q1 2020 May 15, 2020	BUY	$9.11 - $20.05 $1.77 Million - $3.9 Million	194,689 Added 52.66%	564,394 $7.2 Million
Q4 2019 Feb 13, 2020	BUY	$18.47 - $24.03 $6.83 Million - $8.88 Million	369,705 New	369,705 $7.58 Million
Q4 2018 Feb 14, 2019	SELL	$12.68 - $19.01 $1.13 Million - $1.69 Million	-88,960 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.1 - $16.35 $2.16 Million - $2.7 Million	-164,841 Reduced 64.95%	88,960 $1.33 Million
Q2 2018 Aug 14, 2018	SELL	$13.65 - $18.7 $633,933 - $868,465	-46,442 Reduced 15.47%	253,801 $3.69 Million
Q1 2018 May 14, 2018	SELL	$14.85 - $24.3 $299,494 - $490,082	-20,168 Reduced 6.29%	300,243 $4.77 Million
Q4 2017 Feb 09, 2018	BUY	$17.4 - $23.4 $5.58 Million - $7.5 Million	320,411	320,411 $6.55 Million

Others Institutions Holding LNTH

# of Institutions

495

Shares Held

67.2M

Call Options Held

1.19M

Put Options Held

829K

Black Rock Inc. New York, NY

8.6M
Shares

$923 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

7.57M
Shares

$812 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

3.33M
Shares

$358 Million
0.15% of portfolio
State Street Corp Boston, MA

2.49M
Shares

$267 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.28M
Shares

$245 Million
0.89% of portfolio

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.38B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account